ENBREL® (etanercept) | Official Patient Site
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
Enbrel Injections: Uses, Dosage & Side Effects - Drugs.com
2024年7月25日 · Enbrel is a tumor necrosis factor (TNF) blocker. It works by decreasing TNF, a protein produced by the immune system to helps the body fight infections. In people with autoimmune disorders, the immune system produces too …
Rheumatoid Arthritis Treatment | ENBREL® (etanercept)
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
Etanercept - Wikipedia
Etanercept, sold under the brand name Enbrel among others, is a biologic medical product that is used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor.
Enbrel (etanercept) - Uses, Side Effects, and More - WebMD
2024年7月13日 · Enbrel (etanercept) is commonly used for the following conditions. Learn more about Enbrel for Rheumatoid Arthritis. Enbrel may also be used for other conditions as determined by your healthcare...
Injection Information | Enbrel® (etanercept)
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in adult patients with psoriatic arthritis. ENBREL can be used with or without methotrexate.
Dosing Instructions for Enbrel® (etanercept) - enbrelpro.com
ENBREL is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be initiated in combination with methotrexate (MTX) or used alone.
恩利（注射用依那西普）药品说明书 | 辉瑞医学信息网站
有报告使用 TNF-抑制剂，包括恩利，治疗的儿童和青少年患者发生淋巴瘤和其他恶性肿瘤，有些是致命的。 主要成份：依那西普. 辅料：甘露醇、蔗糖和氨丁三醇（Tris）。 活性成份来源：依那西普是利用中国仓鼠卵巢（CHO）细胞表达系统产生的人肿瘤坏死因子受体p75 Fc融合蛋白。 二聚体由人肿瘤坏死因子受体2（TNFR2/p75）的胞外配体结合部位与人IgG1的Fc片段连接组成。 组成依那西普的Fc包括C H 2、C H 3及连接部位，但不包括IgG1的C H 1部分。 依那西普的活 …
- [PDF]
Enbrel - Pfizer
Etanercept (Enbrel) is indicated for reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis (RA). Etanercept (Enbrel) can be initiated in combination with methotrexate or used alone.
依那西普 - 维基百科，自由的百科全书
依那西普 （英語： Etanercept），目前有以Enbrel（恩博） 等商品名稱銷售，是種 生物製藥，有 腫瘤壞死因子抑制劑 （英语：TNF inhibitor） 作用，可干擾 腫瘤壞死因子 （TNF，一種可溶性 促炎細胞因子，舊稱腫瘤壞死因子-α（TNF-α））來治療 自體免疫性疾病，經 美國食品藥物管理局 (FDA) 批准用於治療 類風濕性關節炎 、 幼年特發性關節炎 和 乾癬性關節炎 、 乾癬 和 強直性脊柱炎。 腫瘤壞死因子是造成許多器官系統 發炎 （免疫）反應的"主調節因子"。 自體免疫性疾病 …